04/09/2026
Are you or a loved one looking for different treatment options for relapsed or refractory primary central nervous system lymphoma? You may be eligible for a Phase 1/2 clinical trial at the Ivy Center evaluating emavusertib (CA-4948).
Connect with us today: https://bar.rw/3OukyTw
☎️: 602-406-8605